Black Rock Inc. Mirum Pharmaceuticals, Inc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 3,238,049 shares of MIRM stock, worth $139 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,238,049
Previous 2,452,273
32.04%
Holding current value
$139 Million
Previous $61.6 Million
79.72%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding MIRM
# of Institutions
211Shares Held
53.8MCall Options Held
2.6KPut Options Held
99.7K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.57MShares$283 Million16.29% of portfolio
-
Janus Henderson Group PLC London, X04.58MShares$197 Million0.1% of portfolio
-
Bvf Inc San Francisco, CA2.8MShares$120 Million4.33% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.61MShares$112 Million2.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.42MShares$104 Million0.0% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.58B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...